These suggest that chronic TB could directly (or indirectly, via T-cell exhaustion which leads to either higher levels of immune-inhibitory molecules like PD-1 (71, 72) and TIM3 (73) or reduced release of innate immune cell activators like IFNγ and TNF) result in reduced neutrophil activity pre-treatment. This evidence concerns the gene HAVCR2 and tuberculosis.